Israel’s Yemoja (see here previously) and Israel’s MIGAL Galilee Research Institute are leading a 4-year research initiative to find algae-sourced compounds to help Inflammatory Bowel Disease (IBD) sufferers. The 21-member Algae4IBD consortium has received a €7.5 million EU Horizon 2020 award.

https://www.prnewswire.com/il/news-releases/yemoja-joins-migal-institute-to-pioneer-major-study-of-microalgae-for-inflammatory-bowel-disease-301365044.html